COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give consent for their anonymised health information to be used in this study.
- People who are adults (18 years of age or older).
- People who have Chronic Obstructive Pulmonary Disease (COPD) — a long-term lung condition — that is not well controlled despite being on certain standard inhaler medications, and who have a higher-than-normal level of a particular type of white blood cell (called eosinophils) in their blood (at least 300 cells per microlitre).
- People who have recently been started on a medicine called dupilumab for their COPD, based on their treating doctor's decision, in line with the official approved prescribing guidelines for that medicine.
Who may not be able to join:
- People who are not considered eligible to receive dupilumab according to its official prescribing guidelines.
- People who are currently taking part in another clinical trial involving a treatment or procedure, or who took part in one within the past 12 months, if the treating doctor believes this could affect the results of this study.
- People who have any health condition — whether short-term or long-term — that, in the treating doctor's opinion, would make it difficult to complete questionnaires, take part in the study, or could affect how the study results are interpreted.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 800-633-1610
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Descriptive statistical analysis of socio-demographics; Descriptive statistical analysis of medical disease; Descriptive statistical analysis of treatment history; Descriptive statistical analysis of clinical disease characteristics (symptoms); Descriptive statistical analysis of clinical disease characteristics (exacerbations); Descriptive statistical analysis of clinical disease characteristics (lung function parameters); Descriptive statistical analysis of clinical disease characteristics (max eosinophils [EOS]); Descriptive statistical analysis of clinical disease characteristics (fraction...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.